TNF-α MEDIATED SECRETORY COMPONENT IS POSITIVELY REGULATED BY PI3K/AKT/MTOR IN CACO-2 CELLS

被引:2
|
作者
Liu, Dongyan [1 ,2 ]
Wang, Si
Jiang, Teng
Ding, Peng
机构
[1] China Med Univ, Affiliated Shengjing Hosp, Res Ctr, Shenyang 110004, Liaoning Provin, Peoples R China
[2] China Med Univ, Minist Hlth, Key Lab Congenital Malformat Res, Shenyang 110004, Liaoning Provin, Peoples R China
基金
中国国家自然科学基金;
关键词
secretory component; polymeric Ig receptor; tumour necrosis factor-alpha; phosphoinositide; 3-kinase; mammalian target of rapamycin; POLYMERIC IMMUNOGLOBULIN RECEPTOR; ENTEROTOXIGENIC ESCHERICHIA-COLI; IG RECEPTOR; EXPRESSION; BINDING; PROTEIN; TRANSCYTOSIS; LACTOFERRIN; LINE;
D O I
10.2478/jomb-2013-0008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Secretory component (SC) is the extracellular component of the polymeric immunoglobulin receptor (pIgR) that functions as a receptor for externally secreted polymeric immunoglobulins such as secretory IgA. SC expression is regulated by a signaling pathway involving TNF-alpha. Methods: Caco-2 cells were cotreated with TNF-alpha plus either Wortmannin, which inhibits PI3K, or Rapamycin, which inhibits mTOR. The expression of SC and pIgR mRNA were assessed by immunocytochemistry, Western blotting, and Quantitative real-time PCR. Results: Wortmannin and Rapamycin decreased the fraction of cells expressing SC, as well as the total expression of SC protein and pIgR mRNA. Conclusions: TNF-alpha regulation of SC expression is mediated through a PI3K/AKT/mTOR signaling pathway in Caco-2 cells.
引用
收藏
页码:116 / 120
页数:5
相关论文
共 50 条
  • [31] PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
    Wu, P.
    Hu, Y-Z
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (35) : 4326 - 4341
  • [32] Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway
    Maira, Sauveur-Michel
    Furet, Pascal
    Stauffer, Frederic
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (01) : 137 - 155
  • [33] Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells
    Demirci, Selami
    Dogan, Aysegul
    Apdik, Huseyin
    Tuysuz, Emre Can
    Gulluoglu, Sukru
    Bayrak, Omer Faruk
    Sahin, Fikrettin
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 437 (1-2) : 133 - 142
  • [34] miR-195 suppresses abdominal aortic aneurysm through the TNF-/NF-B and VEGF/PI3K/Akt pathway
    Ma, Xiaohui
    Yao, Hairong
    Yang, Yuhong
    Jin, Long
    Wang, Yu
    Wu, Lina
    Yang, Shengli
    Cheng, Kang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (04) : 2350 - 2358
  • [35] CXC195 induces apoptosis and endoplastic reticulum stress in human hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway
    Chen, Xiao-Liang
    Fu, Jian-Ping
    Shi, Jun
    Wan, Ping
    Cao, Hong
    Tang, Zhi-Mou
    MOLECULAR MEDICINE REPORTS, 2015, 12 (06) : 8229 - 8236
  • [36] miRNA-125a modulates autophagy of thyroiditis through PI3K/Akt/mTOR signaling pathway
    Chen, Danyan
    Huang, Xiaolong
    Lu, Song
    Deng, Huacong
    Gan, Hua
    Huang, Rongxi
    Zhang, Binghan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (04) : 2465 - 2472
  • [37] Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells
    He, Shasha
    Guo, Yuhong
    Zhao, Jingxia
    Xu, Xiaolong
    Wang, Ning
    Liu, Qingquan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [38] MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression
    Huang, Longping
    Sun, Jian
    Ma, Yuteng
    Chen, He
    Tian, Chen
    Dong, Ming
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [39] PI3K/Akt/mTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation
    Sharma, Var Ruchi
    Gupta, Girish Kumar
    Sharma, A. K.
    Batra, Navneet
    Sharma, Daljit K.
    Joshi, Amit
    Sharma, Anil K.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (11) : 1633 - 1638
  • [40] Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
    Tong, Xin
    Pelling, Jill C.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (07) : 971 - 978